EFFECTIVENESS AND SAFETY OF INTRAVENOUS USTEKINUMAB INTENSIFICATION IN CROHN'S DISEASE WITH LOSS OF RESPONSE OR PARTIAL RESPONSE TO SUBCUTANEOUS THERAPY.

Autor:	Bermejo, S. Herrero, Matilla, E. Lobato, Costas, D. Gómez, Fernández, B. Somoza, Briones, P. Ruiz, Villanueva, M. Ferris, Antón, M. D. P. Montero, Díez, Y. Rioja, Burdallo, A. Carrillo, Alonso, A. Herranz, Sáez, M. Sanjurjo
Zdroj:	European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA144-A145, 2p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu